You have 9 free searches left this month | for more free features.

Overall Status

Not yet recruiting (2)

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 2 (2)

phase 1 (1)

Sponsor

Enlivex Therapeutics Ltd. (4)

Enlivex Therapeutics RDO Ltd. (1)

Collaborator

Accelsiors CRO & Consultancy Services (1)

Cato Research (1)

Intervention

allocetra-ots (5)

placebo (2)

nivolumab (1)

Study Documents

Intervention Type

drug (5)

other (2)

Funder Type

Industry (5)

Study Type

Interventional (5)

allocetra-ots

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting

Solid Tumor
+2 more

Allocetra-OTS
nivolumab

Haifa, Israel
+2 more

Oct 12, 2022

Peritoneal Metastases Trial in Ramat Gan (Allocetra-OTS)

Not yet recruiting

Peritoneal Metastases

Allocetra-OTS

Ramat Gan, Israel

The Chaim Sheba Medical Center

Jun 22, 2022

Covid19 Trial in Jerusalem (ALLOCETRA-OTS, Placebo)

Active, not recruiting

Covid19

ALLOCETRA-OTS
Placebo

Jerusalem, Israel

Hadassah Ein Kerem Medical Center

Aug 29, 2022

Sepsis, Community-acquired Pneumonia Trial in Greece, Israel, Spain (ALLOCETRA-OTS, Placebo)

Recruiting

Sepsis
+5 more

Allocetra-OTS
Placebo

Athens, Greece
+14 more

Aug 23, 2022

Covid19 Trial (Allocetra-OTS)

Not yet recruiting

Covid19

Allocetra-OTS

(no location specified)

Aug 17, 2021